Abstract
Soil-transmitted helminthiasis (STH) affects more than one billion people worldwide. WHO aims to control STH as a public health problem by providing periodic anthelminthic treatment to ≥75% of all at-risk children. Tracking progress toward this 2020 goal relies on accurate reporting of drug coverage. For STH, this is difficult because an unknown-but substantial-proportion of deworming occurs outside nationally-administered STH control programs, so-called 'unprogrammed deworming.' Further, coordination of intersectoral efforts needed to administer drugs to different risk groups-and to report coverage to WHO-is inadequate. This paper describes these challenges and offers suggestions to overcome them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
